Search results

Found 5,000 pages
AUTHOR: Kevin Grogan

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Earlier start for new GSK chairman Hampton

Sir Philip Hampton will take over from Sir Christopher Gent as chairman of GlaxoSmithKline on May 7, nearly four months earlier than expected. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/earlier_start_for_new_gsk_chairman_hampton_971116

Recordati acquires Tunisia's Opalia

Recordati is buying a 90% stake in Opalia Pharma of Tunisia in a deal valued at 80 million dinar, or around 37 million euros. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/recordati_acquires_tunisias_opalia_1005440

Europe approves Bayer's Jaydess

Bayer has been given the green light by Europe's regulator to market its new long-term contraceptive Jaydess which provides prevention of pregnancy for up to three years. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/europe_approves_bayers_jaydess_976096

SMC backs Alimera eye drug

Scottish diabetics with a condition that causes blurred or double vision will be cheered by the news that Alimera Sciences' Iluvien has been backed by the country's cost watchdog. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/smc_backs_alimera_eye_drug_1001518

Watson sued over generic Viagra

Watson Pharmaceuticals is being sued by Pfizer over its plans to market a generic version of the US giant's erectile dysfunction drug Viagra. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/watson_sued_over_generic_viagra_980937

Roche buys German genomics group Signature

Roche has hit the acquisition trail again to buy privately-held Signature Diagnostics of Germany. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/roche_buys_german_genomics_group_signature_971024

Eisai files lenvatinib for thyroid cancer

Eisai has filed its anticancer agent lenvatinib with regulators on both sides of the Atlantic. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/eisai_files_lenvatinib_for_thyroid_cancer_1002345

Chinese officials inspect UCB offices

As a bribery scandal continues to engulf GlaxoSmithKline in China, UCB has revealed that its offices have been visited by authorities this week. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/chinese_officials_inspect_ucb_offices_1005402

AZ gets EU approval for COPD combo

AstraZeneca says that Duaklir Genuair, from the Almirall respiratory portfolio it recently purchased, has been given the green light from regulators in Europe for chronic obstructive pulmonary disease. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/az_gets_eu_approval_for_copd_combo_1002809

AZ signs antibiotic pact with FOB

AstraZeneca has linked up with the USA's FOB Synthesis for the development of a novel antibiotic to treat drug-resistant bacterial infections. - News - PharmaTimes

by Kevin Grogan

www.pharmatimes.com/news/az_signs_antibiotic_pact_with_fob_1001428

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download